News
The NHS Saves £1.2 Billion On Medications Over Three Years
The NHS has used its purchasing power to negotiate lower rates for dozens of hospital medications, saving taxpayers £1.2 billion in only three years while obtaining cutting-edge therapies for patients.
One third of the savings have been attributable to the...
News
World Biopharmaceutical Bioseparation Sector Aiming $20bn
Recent market analysis predicts that the international market for biopharmaceutical bioseparation systems, which is expected to be worth $13 billion in 2022, will increase to $19.6 billion by 2026, growing at a 13.2%Â compound annual growth rate (CAGR).
According to the...
News
Omicron-Specific COVID-19 Vaccinations Can Act As Boosters
According to the European Medicines Agency and other international health agencies, coronavirus vaccinations that have been modified to incorporate the omicron variant strain can provide better protection when administered as a booster. Following a meeting on June 30th, the...
News
AstraZeneca Claims Research Success In Early Lung Cancer
The most prevalent kind of the disease, non-small cell lung cancer, has seen steady advancements in immunotherapies called checkpoint inhibitors during the past ten years. First, medications like Keytruda from Merck & Co., Opdivo from Bristol-Myers Squibb, and Tecentriq...
News
US FDA Advisers Advocate Changing Fall COVID Vaccine Dosage
To address more recently circulating coronavirus strains, advisors to the U.S. Food and Drug Administration recently suggested altering the design of COVID-19 booster doses this fall. The next round of COVID booster shots should contain a component that combats the...
Articles
How to tackle top healthcare logistics challenges in 2022
Combining the power of network with data paves the way for better logistical support for healthcare players.Â
The latest wave of COVID-19 infections has made its way across East Asia, with Hong Kong, Shanghai and Beijing, reporting record numbers...
News
Australia Introduces A Fresh Outlook To Stem Cell Production
A novel 3D printed methodology for extracting stem cells from bioreactors has been created by researchers at the University of Technology, Sydney, opening the door to the possibility of high-quality, mass-produced stem cells in Australia at a cheaper price.
Due...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.